BioSpace News Archive

Preparative and Process Chromatography Market in 2021 - Detailed Analysis Report

The preparative and process chromatography market is anticipated to display phenomenal growth rate over the forecast period from 2020 to 2030.

July 6, 2021
·
3 min read
Handheld Drug Detector Market – A Study on Portable Devices Used For Drug Detection

Illicit consumption and distribution of controlled substances such as narcotics are noteworthy public safety issues in numerous countries worldwide.

July 6, 2021
·
3 min read
FDA

CytoSorbents Receives Full FDA Approval of Investigational Device Exemption (IDE) for U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery

CytoSorbents Corporation announces the full approval of its Investigational Device Exemption application to conduct the pivotal STAR-T double-blind, randomized, controlled trial in the United States to support FDA regulatory clearance.

July 6, 2021
·
8 min read
Drug Development

4D pharma Announces Publication of Preclinical Research Showing Single Strain Megasphaera massiliensis improves activity of CAR-T

4D pharma plc today announces the publication of pre-clinical research relating to its second-generation immuno-oncology LBP MRx1299 improving the activity of CAR-T.

July 6, 2021
·
6 min read
Pharm Country

Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference

Immunome, Inc. today announced that Purnanand Sarma, Ph.D., Immunome’s President and CEO, will present at the Ladenburg Thalmann 2021 Healthcare Conference on Tuesday, July 13, 2021, at 10:30 a.m. ET.

July 6, 2021
·
3 min read
Policy

New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics’ Stelfonta®

QBiotics Group Limited, an Australian life sciences company developing novel small molecule anticancer and wound healing pharmaceuticals, is pleased to announce the Australian Pesticides and Veterinary Medicines Authority has approved* its lead veterinary product STELFONTA®.

July 6, 2021
·
4 min read
Business

Mesa Labs Declares Quarterly Dividend - July 06, 2021

Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

July 6, 2021
·
2 min read
Biotech Beach

Adagio Medical Announces First-In-Human Use and Initiation of Multi-Center Study of Ultra-Low Temperature Cryoablation for Treatment of Recurrent Ventricular Tachycardia, Opening New Possibilities for High-Risk Patients

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic VT.

July 6, 2021
·
3 min read
Business

Extendicare Announces Timing of 2021 Second Quarter Results and Conference Call

Extendicare Inc. announced that it plans to release its financial results for the second quarter of 2021 after market close on Thursday, August 5, 2021.

July 6, 2021
·
1 min read
Pharm Country

Y-mAbs Announces NMPA Submission of BLA for DANYELZA® (naxitamab-gqgk) in China

Y-mAbs Therapeutics, Inc. today announced that SciClone Pharmaceuticals (Holdings) Limited (“SciClone Pharmaceuticals”) has submitted the Biologics License Application (“BLA”) for DANYELZA® (naxitamab-gqgk) for the treatment of patients with relapsed/refractory neuroblastoma.

July 6, 2021
·
5 min read